NYSE: ESRTEmpire State Realty Trust Inc Stock
$8.05+0.10 (+1.26%)
Updated Mar 26, 2025
ESRT Price
$8.05
Fair Value Price
N/A
Market Cap
$1.35B
52 Week Low
$7.88
52 Week High
$11.62
P/E
27.76x
P/B
1.31x
P/S
2.22x
PEG
54.06x
Dividend Yield
1.74%
Revenue
$767.92M
Earnings
$51.64M
Gross Margin
53.9%
Operating Margin
21.36%
Profit Margin
6.2%
Debt to Equity
2.65
Operating Cash Flow
$261M
Beta
1.12
Next Earnings
Apr 22, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ESRT Overview
Empire State Realty Trust, Inc., a real estate investment trust (REIT), owns and manages office and retail properties in Manhattan and the greater New York metropolitan area, including its namesake, the Empire State Building. Empire State Realty Trust's portfolio includes 13 other office properties (9.4M rentable square feet of office space). The company was founded in 2013 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ESRT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Diversified REIT
Industry Rating
D
ESRT
Ranked#10 of 17
Ranked#10 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.92 | C | |
| $26.56 | C | |
| $7.99 | C |
Be the first to know about important ESRT news, forecast changes, insider trades & much more!
ESRT News
Overview
Due Diligence Score
–
Industry Average (20)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ESRT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ESRT ($8.05) is trading above its intrinsic value of $1.64, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ESRT is good value based on its earnings relative to its share price (27.76x), compared to the US market average (31.65x)
P/E vs Market Valuation
ESRT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ESRT due diligence checks available for Premium users.
Valuation
ESRT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
27.76x
Industry
17.26x
Market
31.65x
ESRT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ESRT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ESRT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.31x
Industry
1.25x
ESRT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ESRT price to earnings growth (PEG)
For valuing profitable companies with growth potential
ESRT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
ESRT's financial health
Profit margin
Revenue
$197.6M
Net Income
$12.2M
Profit Margin
5.7%
ESRT's Earnings (EBIT) of $164.04M... subscribe to Premium to read more.
Interest Coverage Financials
ESRT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.5B
Liabilities
$2.7B
Debt to equity
2.65
ESRT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ESRT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$50.0M
Investing
-$78.7M
Financing
-$12.0M
ESRT's operating cash flow ($260.89M)... subscribe to Premium to read more.
Debt Coverage Financials
ESRT vs Diversified REIT Stocks
Empire State Realty Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.